Drug-Induced Lupus: Clinical Spectrum and Pathogenesis
- 1 July 1985
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 290 (1), 36-45
- https://doi.org/10.1097/00000441-198507000-00007
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- HYDRALAZINE-INDUCED LUPUS: NO ASSOCIATION WITH HLA-DR4The Lancet, 1984
- Reactivity of anti-histone antibodies induced by procainamide and hydralazineClinical Immunology and Immunopathology, 1982
- The chemical induction of systemic lupus erythematosus and lupus‐like illnessesArthritis & Rheumatism, 1981
- Methyldopa Inhibition of Suppressor-Lymphocyte FunctionNew England Journal of Medicine, 1980
- Antibodies to Nuclear Antigens in Patients Treated with Procainamide or AcetylprocainamideNew England Journal of Medicine, 1979
- Cross-reactivity of antilymphocyte and antinuclear antibodies in systemic lupus erythematosusClinical Immunology and Immunopathology, 1979
- Circulating immune complexes in sera from patients receiving procainamideClinical Immunology and Immunopathology, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- The interaction of lupus-inducing drugs with deoxyribonucleic acidClinical Immunology and Immunopathology, 1974
- Studies on the Control of Hypertension by HyphexCirculation, 1953